Member Exclusive Interview

A step towards making AI accessible to all researchers: an interview with John Overington

Last week, Medicines Discovery Catapult (Cheshire, UK) and Chief.AI announced they will be working together to make artificial intelligence more accessible for all researchers. We spoke with John Overington (Medicines Discovery Catapult) to learn more about the use of artificial intelligence in drug discovery.

Please sign in or register for FREE

No comments yet.